SANDFORD D SMITH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDFORD D SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in QLT INC/BC ($QLTI) and Director in APRICUS BIOSCIENCES, INC. ($APRI) and Director in CYTOKINETICS INC ($CYTK) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Neuralstem, Inc. ($CUR) and Director in AKCEA THERAPEUTICS, INC. ($AKCA).
Latest Insider Trading Transactions of SANDFORD D SMITH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
| May 13 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Grant | A | 0.00 | 5,000 | 0 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.68 | 5,000 | 53,400 | 15,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.55 | 4,739 | 49,996 | 0 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 28.00 | 5,000 | 140,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.68 | 5,000 | 53,400 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.50 | 4,739 | 130,323 | 920 | 5.7 K to 920 (-83.74 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.55 | 4,739 | 49,996 | 5,659 | 920 to 5.7 K (+515.11 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 5,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 5,000 | 135,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 5,000 | |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 5,000 | 135,000 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 27 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 10,000 | |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 26.50 | 5,000 | 132,500 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 23 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 9.45 | 5,000 | 47,250 | 15,000 | |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 8.75 | 5,714 | 49,998 | 0 | |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 25.00 | 5,714 | 142,850 | 920 | 6.6 K to 920 (-86.13 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 8.75 | 5,714 | 49,998 | 6,634 | 920 to 6.6 K (+621.09 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 25.50 | 5,000 | 127,500 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 15 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 9.45 | 5,000 | 47,250 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 10.00 | 4,375 | 43,750 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 5,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 10,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.61 | 5,000 | 38,050 | 15,000 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.82 | 3,207 | 21,872 | 0 | |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 24.50 | 4,375 | 107,188 | 920 | 5.3 K to 920 (-82.63 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 10.00 | 4,375 | 43,750 | 5,295 | 920 to 5.3 K (+475.54 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,950 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,943 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.80 | 5,000 | 118,995 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.79 | 5,000 | 118,948 | 920 | 5.9 K to 920 (-84.46 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.61 | 5,000 | 38,050 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 24.00 | 3,207 | 76,968 | 920 | 4.1 K to 920 (-77.71 %) |
| Apr 12 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.82 | 3,207 | 21,872 | 4,127 | 920 to 4.1 K (+348.59 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 12.21 | 52,837 | 645,140 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.14 | 26,400 | 426,096 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | D | 12.21 | 52,837 | 645,140 | 0 | |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.37 | 5,936 | 43,748 | 0 | |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 30.00 | 5,936 | 178,080 | 0 | 5.9 K to 0 (-100.00 %) |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.37 | 5,936 | 43,748 | 5,936 | 0 to 5.9 K |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 7.37 | 5,936 | 43,748 | 0 | |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 30.00 | 5,936 | 178,080 | 0 | 5.9 K to 0 (-100.00 %) |
| Oct 05 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 7.37 | 5,936 | 43,748 | 5,936 | 0 to 5.9 K |
| Jul 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.21 | 6,667 | 41,402 | 0 | |
| Jul 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 29.00 | 6,667 | 193,343 | 0 | 6.7 K to 0 (-100.00 %) |
| Jul 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.21 | 6,667 | 41,402 | 6,667 | 0 to 6.7 K |
| Jul 13 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.21 | 6,667 | 41,402 | 6,667 | |
| Jul 13 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 28.00 | 6,667 | 186,676 | 0 | 6.7 K to 0 (-100.00 %) |
| Jul 13 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.21 | 6,667 | 41,402 | 6,667 | 0 to 6.7 K |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.72 | 6,510 | 43,747 | 0 | |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.21 | 1,434 | 8,905 | 13,334 | |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.21 | 5,232 | 32,491 | 14,768 | |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 1,434 | 38,718 | 0 | 1.4 K to 0 (-100.00 %) |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.21 | 1,434 | 8,905 | 1,434 | 0 to 1.4 K |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 26.00 | 6,510 | 169,260 | 0 | 6.5 K to 0 (-100.00 %) |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.72 | 6,510 | 43,747 | 6,510 | 0 to 6.5 K |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 27.00 | 5,232 | 141,264 | 0 | 5.2 K to 0 (-100.00 %) |
| Jul 09 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.21 | 5,232 | 32,491 | 5,232 | 0 to 5.2 K |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 4.44 | 5,000 | 22,200 | 0 | |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 4.44 | 5,000 | 22,200 | 5,000 | |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 24.00 | 5,000 | 120,000 | 0 | 5 K to 0 (-100.00 %) |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 4.44 | 5,000 | 22,200 | 5,000 | 0 to 5 K |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 25.00 | 5,000 | 125,000 | 0 | 5 K to 0 (-100.00 %) |
| Jun 22 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 4.44 | 5,000 | 22,200 | 5,000 | 0 to 5 K |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.84 | 2,741 | 18,748 | 0 | |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.78 | 4,166 | 28,245 | 0 | |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.00 | 2,741 | 63,043 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.84 | 2,741 | 18,748 | 2,741 | 0 to 2.7 K |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 23.00 | 4,166 | 95,818 | 0 | 4.2 K to 0 (-100.00 %) |
| Jun 17 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.78 | 4,166 | 28,245 | 4,166 | 0 to 4.2 K |
| Jun 15 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 6.30 | 6,666 | 41,996 | 0 | |
| Jun 15 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 22.00 | 6,666 | 146,652 | 0 | 6.7 K to 0 (-100.00 %) |
| Jun 15 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 6.30 | 6,666 | 41,996 | 6,666 | 0 to 6.7 K |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 5.46 | 4,166 | 22,746 | 0 | |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | M | 4.02 | 10,879 | 43,734 | 0 | |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 21.10 | 4,166 | 87,903 | 0 | 4.2 K to 0 (-100.00 %) |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 5.46 | 4,166 | 22,746 | 4,166 | 0 to 4.2 K |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Sell | S | 20.77 | 10,879 | 226,005 | 0 | 10.9 K to 0 (-100.00 %) |
| Jun 12 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Buy | M | 4.02 | 10,879 | 43,734 | 10,879 | 0 to 10.9 K |
| May 14 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 21.61 | 20,000 | 432,200 | 20,000 | |
| Apr 15 2020 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | A | 16.14 | 26,400 | 426,096 | 26,400 | |
| Feb 14 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 15.43 | 4,124 | 63,633 | 4,124 | |
| Jan 06 2020 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 10.55 | 758 | 7,997 | 758 | |
| Jul 03 2019 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 166,667 | 0 | 219,916 | 53.2 K to 219.9 K (+313.00 %) |
| Jun 18 2019 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | A | 22.74 | 26,400 | 600,336 | 26,400 | |
| May 17 2019 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 10.68 | 20,000 | 213,600 | 20,000 | |
| Jan 04 2019 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 6.82 | 3,207 | 21,872 | 3,207 | |
| Jul 05 2018 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 45,046 | 0 | 50,899 | 5.9 K to 50.9 K (+769.62 %) |
| Jun 05 2018 | AKCA | AKCEA THERAPEUTICS ... | SMITH SANDFORD D | Director | Option Exercise | A | 23.46 | 26,400 | 619,344 | 26,400 | |
| May 17 2018 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 9.45 | 20,000 | 189,000 | 20,000 | |
| Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
| Jan 04 2018 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 8.75 | 5,714 | 49,998 | 5,714 | |
| Jul 18 2017 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Option Exercise | A | 0.00 | 9,311 | 0 | 9,311 | |
| May 22 2017 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
| Jan 31 2017 | QLTI | NOVELION THERAPEUT ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 456 | 0 | 1,367 | |
| Jan 31 2017 | QLTI | NOVELION THERAPEUT ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 9.38 | 148 | 1,388 | 900 | 1 K to 900 (-14.12 %) |
| Jan 31 2017 | QLTI | NOVELION THERAPEUT ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 456 | 0 | 1,048 | 592 to 1 K (+77.03 %) |
| Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.00 | 11,250 | 0 | 16,160 | 4.9 K to 16.2 K (+229.12 %) |
| Jan 04 2017 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 12.40 | 4,032 | 49,997 | 4,032 | |
| Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | SMITH SANDFORD D | Director | Option Exercise | A | 8.65 | 9,600 | 83,040 | 9,600 | |
| Dec 01 2016 | QLTI | QLT INC/BC | SMITH SANDFORD D | Director | Option Exercise | A | 0.00 | 9,115 | 0 | 9,115 | |
| Dec 01 2016 | QLTI | QLT INC/BC | SMITH SANDFORD D | Director | Grant | A | 0.00 | 2,963 | 0 | 2,963 | 0 to 3 K |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 0.00 | 8,888 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 18.26 | 40,000 | 730,400 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 15.00 | 8,569 | 128,535 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.28 | 16,435 | 267,562 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Sell | D | 0.00 | 2,890 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
| Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.34 | 9,607 | 3,250 | 49,093 | 39.5 K to 49.1 K (+24.33 %) |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,222 | 0 | 8,888 | |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 1.55 | 777 | 1,204 | 2,890 | 3.7 K to 2.9 K (-21.19 %) |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,222 | 0 | 3,667 | 1.4 K to 3.7 K (+153.77 %) |
| Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.40 | 8,136 | 3,250 | 39,486 | 31.4 K to 39.5 K (+25.95 %) |
| May 20 2016 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
| Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.58 | 4,850 | 2,813 | 31,350 | 26.5 K to 31.4 K (+18.30 %) |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,223 | 0 | 11,110 | |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 6.78 | 778 | 5,275 | 1,445 | 2.2 K to 1.4 K (-35.00 %) |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,223 | 0 | 2,223 | 0 to 2.2 K |
| Jan 06 2016 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 10.00 | 4,375 | 43,750 | 4,375 | |
| Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
| Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 0.00 | 13,333 | 0 | 13,333 | |
| Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 18.26 | 40,000 | 730,400 | 40,000 | |
| Jul 06 2015 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 106,952 | 0 | 106,952 | 0 to 107 K |
| Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
| May 21 2015 | CYTK | CYTOKINETICS INC | SMITH SANDFORD D | Director | Option Exercise | A | 6.21 | 20,000 | 124,200 | 20,000 | |
| Dec 01 2004 | ARIA | ARIAD PHARMACEUTIC ... | SMITH SANDFORD D | Director | Option Exercise | M | 2.00 | 10,000 | 20,000 | 0 | |
| Dec 01 2004 | ARIA | ARIAD PHARMACEUTIC ... | SMITH SANDFORD D | Director | Buy | M | 2.00 | 10,000 | 20,000 | 66,205 | 56.2 K to 66.2 K (+17.79 %) |
Page: 1